Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer
The Uromigos - Un pódcast de The Uromigos
Mike Atkins describes the results of this study which helps shed light on the role of ipilimumab and nivolumab in this disease.
